Vaccine Therapy and Pembrolizumab in Treating Patients With Solid Tumors That Have Failed Prior Therapy

Clinical trial NCT02432963 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT02432963
Sponsor: City of Hope Medical Center
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Adult Solid Neoplasm Bladder Carcinoma Colon Carcinoma Estrogen Receptor Negative Head and Neck Squamous Cell Carcinoma Hepatocellular Carcinoma HER2/Neu Negative Melanoma Non-Small Cell Lung Carcinoma Pancreatic Carcinoma Progesterone Receptor Negative Rectal Carcinoma

Start date: 2016-06-14
Primary completion: 2017-12-04
Enrollment: 11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.